IOL Chemicals and Pharmaceuticals Limited Total Liabilities
IOL Chemicals and Pharmaceuticals Limited total liabilities. Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) has total liabilities worth Rs7.88 Billion INR (≈ $85.26 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IOLCP asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of IOL Chemicals and Pharmaceuticals Limited (2005–2026)
Total liabilities of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026. This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore IOLCP long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
IOL Chemicals and Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of IOL Chemicals and Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Water Business Doctor
SHE:300055
|
China | CN¥3.21 Billion |
|
Anpec Electronics
TWO:6138
|
Taiwan | NT$1.74 Billion |
|
SIS LIMITED
NSE:SIS
|
India | Rs50.87 Billion |
|
Shenzhen Kaizhong Precision Technology Co Ltd
SHE:002823
|
China | CN¥1.57 Billion |
|
Shen Zhen Bauing Construction Holding Group Co Ltd
SHE:002047
|
China | CN¥1.25 Billion |
|
Bridgewater Bancshares Inc
NASDAQ:BWB
|
USA | $4.84 Billion |
|
Chong Kun Dang Pharmaceutical
KO:185750
|
Korea | ₩803.02 Billion |
|
Obrascon Huarte Lain SA
MC:OHLA
|
Spain | €2.84 Billion |
Liability Composition Analysis (2005–2026)
This chart breaks down IOL Chemicals and Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IOL Chemicals and Pharmaceuticals Limite (IOLCP) total assets.
Liquidity & Leverage Metrics
IOL Chemicals and Pharmaceuticals Limited Total Liabilities Ratios Explained
IOL Chemicals and Pharmaceuticals Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IOL Chemicals and Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IOL Chemicals and Pharmaceuticals Limited (2005–2026)
The table below shows the annual total liabilities of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs7.88 Billion ≈ $85.26 Million |
+13.54% |
| 2025-03-31 | Rs6.94 Billion ≈ $75.10 Million |
+9.72% |
| 2024-03-31 | Rs6.33 Billion ≈ $68.44 Million |
+23.03% |
| 2023-03-31 | Rs5.14 Billion ≈ $55.63 Million |
-9.76% |
| 2022-03-31 | Rs5.70 Billion ≈ $61.65 Million |
+63.02% |
| 2021-03-31 | Rs3.50 Billion ≈ $37.81 Million |
-1.85% |
| 2020-03-31 | Rs3.56 Billion ≈ $38.53 Million |
-23.80% |
| 2019-03-31 | Rs4.68 Billion ≈ $50.56 Million |
-26.53% |
| 2018-03-31 | Rs6.36 Billion ≈ $68.82 Million |
+1.21% |
| 2017-03-31 | Rs6.29 Billion ≈ $68.00 Million |
+7.06% |
| 2016-03-31 | Rs5.87 Billion ≈ $63.52 Million |
+18.79% |
| 2015-03-31 | Rs4.94 Billion ≈ $53.47 Million |
-7.04% |
| 2014-03-31 | Rs5.32 Billion ≈ $57.52 Million |
-3.99% |
| 2013-03-31 | Rs5.54 Billion ≈ $59.91 Million |
+7.91% |
| 2012-03-31 | Rs5.13 Billion ≈ $55.52 Million |
+17.33% |
| 2011-03-31 | Rs4.38 Billion ≈ $47.32 Million |
+21.52% |
| 2010-03-31 | Rs3.60 Billion ≈ $38.94 Million |
+22.39% |
| 2009-03-31 | Rs2.94 Billion ≈ $31.82 Million |
+88.13% |
| 2008-03-31 | Rs1.56 Billion ≈ $16.91 Million |
+8.78% |
| 2007-03-31 | Rs1.44 Billion ≈ $15.55 Million |
+88.89% |
| 2006-03-31 | Rs761.01 Million ≈ $8.23 Million |
+53.56% |
| 2005-03-31 | Rs495.59 Million ≈ $5.36 Million |
-- |
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more